Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Alendronate Sodium Articles

Sanofi's Mid-term Pipeline "One Of The Most Promising

23 October 1995

New York Stock Comment

16 October 1995

USA Lags Foreign Approvals, PhRMA Demonstrates

16 October 1995

New York stock comment

9 October 1995

Merck's Fosamax Cleared For US Marketing

9 October 1995

Merck Sharp and Dohme launch Fosamax in UK

11 September 1995

Sandoz' Calcitonin Spray Approved

11 September 1995

NEW YORK STOCK COMMENT

24 July 1995

Merck's Fosamax Nears Market In USA

24 July 1995

Good Profits Performance Expected At Sanofi

24 July 1995

NEW YORK STOCK COMMENT

17 July 1995

Solid 2nd Qtr Earnings Growth For US Drugmakers

17 July 1995

Merck pipline report

3 July 1995

Merck gets Fosamax approval

3 July 1995

Merck's Fosamax Set For Rapid US Approval?

12 June 1995

NEW YORK STOCK COMMENT

6 March 1995

PH II RESULTS OF PROSCAR BALDNESS TRIALS

25 April 1994

TILUDRONATE EFFICACY SHOWN

4 April 1994

PREVENTION PRIORITIES FOR OSTEOPOROSIS

28 March 1994

MERCK FILES NDAs FOR COZAAR WORLDWIDE

21 February 1994

FOSAMIX INCREASES BONE DENSITY

27 September 1993

Showing 201-221 of 221 articles

Go to beginningPrevious
  • 1
  • 2
  • 3
NextGo to end
  • Hot Topics
  • Most Read
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • New study shows UCB's Neupro reduces NSBP in RLS patient
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • New study shows UCB's Neupro reduces NSBP in RLS patient

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS